Across TCGA pan-cancer cohorts, OR52J3 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of OR52J3’s most consistent transcriptional readouts.

The strongest signal is observed in prostate adenocarcinoma (PRAD), where OR52J3 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR52J3 is over-expressed in tumor.

PRAD are the cancer types where OR52J3 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR52J3 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
PRAD	All	All	+0.024	.020	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: OR52J3 RNA expression & survival · all OR52J3 data types